2025-04-24 - Analysis Report
## Teladoc Health Inc (TDOC) Stock Review

**0) Executive Summary:**

Teladoc Health Inc (TDOC) is a telehealth company providing virtual care services.  The stock has significantly underperformed the S&P 500 (VOO) over the analyzed period, showing substantial losses. Recent financial performance reveals consistent revenue but fluctuating profitability and negative ROE.  Technical indicators suggest a potentially oversold condition, but significant risks remain.


**1) Performance Comparison:**

Teladoc Health Inc (TDOC) provides virtual care services.

* **TDOC Cumulative Return:** -70.08%
* **VOO (S&P 500) Cumulative Return:** 74.29%
* **Return Difference:** -144.4% (This represents the difference between TDOC's return and VOO's return.  The relative divergence of -4.4% positions TDOC in the lower 4.4% of historical performance relative to VOO, based on a range of minimum -171.5% to maximum 447.1% divergence.)

**Alpha and Beta Analysis:**

The provided data shows highly volatile performance for TDOC, with significant swings in CAGR (Compound Annual Growth Rate) and MDD (Maximum Drawdown).  While early periods show high growth and positive alpha, recent years have exhibited massive negative returns and negative alpha, indicating consistent underperformance against the market (as represented by beta).  The shrinking market capitalization (Cap(B)) also highlights shrinking investor confidence.

| Year       | CAGR   | MDD    | Alpha | Beta | Cap(B) |
|------------|--------|--------|-------|-------|--------|
| 2015-2017  | 76.0%  | 60.6%  | 49.0% | 0.0   | 6.1    |
| 2016-2018  | 128.0% | 59.3%  | 109.0%| 0.0   | 8.7    |
| 2017-2019  | 176.0% | 59.3%  | 145.0%| 0.4   | 14.7   |
| 2018-2020  | 237.0% | 64.0%  | 208.0%| 0.2   | 35.0   |
| 2019-2021  | -83.0% | 64.0%  | -141.0%| 0.2   | 16.1   |
| 2020-2022  | -295.0%| 81.3%  | -303.0%| 0.0   | 4.2    |
| 2021-2023  | -488.0%| 81.3%  | -508.0%| -0.6  | 3.8    |
| 2022-2024  | -111.0%| 81.3%  | -131.0%| -0.9  | 1.6    |
| 2023-2025  | -41.0% | 72.9%  | -57.0% | -0.8  | 1.2    |


**2) Recent Price Movement:**

* **Closing Price:** $7.07
* **Previous Close:** $6.90
* **Daily Change:** +2.46%
* **5-Day Moving Average:** $6.84
* **20-Day Moving Average:** $7.45
* **60-Day Moving Average:** $9.46

The price is currently below all three moving averages, suggesting a bearish trend. The recent 2.46% increase might be a temporary bounce.

**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4174 (Medium Risk)
* **RSI:** 39.09 (Approaching oversold territory, but not decisively so)
* **PPO:** 0.19 (Positive, but low suggesting weak momentum)
* **20-Day Relative Divergence Change:** -0.1 (Short-term bearish)
* **Expected Return:** -1999.4% (This extremely negative figure suggests a very high level of risk and a significant potential for further losses.  It's crucial to critically evaluate the methodology used to calculate this.)
* **Recent Price Change Note:** The recent small price increase (2.46%) is not significant enough to be labeled a "sharp rebound."

**4) Recent Earnings Analysis:**

The company consistently reports negative EPS and relatively flat revenue.  This suggests a concerning lack of profitability.

| Date       | EPS     | Revenue       |
|------------|---------|---------------|
| 2024-10-31 | -$0.19  | $0.64B        |
| 2024-08-01 | -$4.92  | $0.64B        |
| 2024-04-26 | -$0.49  | $0.65B        |
| 2023-10-27 | -$0.35  | $0.66B        |
| 2024-10-31 | -$0.35  | $0.66B        |


**5) Financial Information:**

Revenue remains relatively stable, but profit margins are fluctuating.  More importantly, the Return on Equity (ROE) is consistently negative, indicating the company is not generating sufficient returns for its shareholders.  This is a significant red flag.

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2024-12-31 | $0.64B   | 70.50%        |
| 2024-09-30 | $0.64B   | 71.94%        |
| 2024-06-30 | $0.64B   | 70.73%        |
| 2024-03-31 | $0.65B   | 69.89%        |
| 2023-12-31 | $0.66B   | 70.72%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE     |
|------------|----------|---------|
| 2024-12-31 | $1.49B   | -3.25%  |
| 2024-09-30 | $1.51B   | -2.21%  |
| 2024-06-30 | $1.50B   | -55.77% |
| 2024-03-31 | $2.29B   | -3.58%  |
| 2023-12-31 | $2.33B   | -1.24%  |


**6) Overall Analysis:**

TDOC's performance has been extremely poor, significantly underperforming the S&P 500.  While some technical indicators suggest potential oversold conditions, the consistently negative EPS, fluctuating profit margins, and severely negative ROE paint a grim picture of the company's financial health.  The extremely negative projected return (-1999.4%) further underscores the substantial risks involved.  Before considering any investment in TDOC, a thorough reassessment of the company's business model and future prospects is crucial.  The current data strongly suggests high risk and potential for further losses.  The -1999.4% expected return should be treated with extreme caution and needs validation.  Without understanding the model used to calculate this extreme value, this number is not useful for investment decision-making.
